Processes and intermediates for preparing mcl1 inhibitors
US-2026055068-A1 · Feb 26, 2026 · US
the carbon skeleton being further substituted by singly-bound oxygen atoms
the carbon skeleton being further substituted by singly-bound oxygen atoms · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07C229/64 |
| Official title | the carbon skeleton being further substituted by singly-bound oxygen atoms |
| Display label | the carbon skeleton being further substituted by singly-bound oxygen atoms |
| Total patents | 49 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Processes and intermediates for preparing MCL1 inhibitors
US-12410146-B2 · Sep 9, 2025 · US
Salt crystals
US-2025129087-A1 · Apr 24, 2025 · US
Novel small molecule inhibitors of tead transcription factors
US-2025122194-A1 · Apr 17, 2025 · US
EBNA1 inhibitors and their method of use
US-12258314-B2 · Mar 25, 2025 · US
Small molecule inhibitors of TEAD transcription factors
US-12187722-B2 · Jan 7, 2025 · US
Processes and intermediates for preparing mcl1 inhibitors
US-2024109851-A1 · Apr 4, 2024 · US
Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
US-11883383-B2 · Jan 30, 2024 · US
Ester compound
US-2024025838-A1 · Jan 25, 2024 · US
Processes and intermediates for preparing MCL1 inhibitors
US-11760736-B2 · Sep 19, 2023 · US
Novel small molecule inhibitors of tead transcription factors
US-2023113085-A1 · Apr 13, 2023 · US
Processes and intermediates for preparing mcl1 inhibitors
US-2023013713-A1 · Jan 19, 2023 · US
EBNA1 Inhibitors and Their Method of Use
US-2022396551-A1 · Dec 15, 2022 · US
Small molecule inhibitors of the mcl-1 oncoprotein and uses therof
US-2022396549-A1 · Dec 15, 2022 · US
Agonists of peroxisome proliferator-activated receptor alpha and methods of use
US-11447452-B2 · Sep 20, 2022 · US
Processes and intermediates for preparing MCL1 inhibitors
US-11325891-B2 · May 10, 2022 · US
EBNA1 inhibitors and their method of use
US-11242317-B2 · Feb 8, 2022 · US
Compositions and methods for the treatment of chronic pain
US-2021244687-A1 · Aug 12, 2021 · US
Processes and intermediates for preparing mcl1 inhibitors
US-2021179570-A1 · Jun 17, 2021 · US
Acid addition salts of apomorphine, pharmaceutical compositions containing the same, and methods of using the same
US-2021179561-A1 · Jun 17, 2021 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07C229/64?
- CPC C07C229/64 is the Cooperative Patent Classification code for “the carbon skeleton being further substituted by singly-bound oxygen atoms.”
- How many patents are filed under CPC C07C229/64 (the carbon skeleton being further substituted by singly-bound oxygen atoms)?
- Our database includes 49 publications tagged with this CPC code.
- Is patent activity under CPC C07C229/64 growing?
- Publication counts under this code: 3 in 2024 vs 5 in 2025 (latest complete years).